Izotropic Corporation (OTCMKTS:IZOZF) Sees Significant Decrease in Short Interest

Izotropic Corporation (OTCMKTS:IZOZF) was the recipient of a large decrease in short interest during the month of October. As of October 30th, there was short interest totaling 9,609 shares, a decrease of 89.6% from the October 15th total of 92,598 shares. Based on an average trading volume of 67,127 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are sold short.

Izotropic Price Performance

Shares of IZOZF remained flat at $0.09 during mid-day trading on Thursday. 40,347 shares of the stock traded hands, compared to its average volume of 40,574. Izotropic has a one year low of $0.07 and a one year high of $0.29. The stock has a 50 day moving average of $0.13 and a 200-day moving average of $0.17.

Izotropic (OTCMKTS:IZOZF) last announced its earnings results on Monday, September 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). On average, sell-side analysts anticipate that Izotropic will post 0.03 earnings per share for the current fiscal year.

About Izotropic

Izotropic Corporation is a medical technology company focused on developing dedicated breast computed tomography (CT) imaging systems. Its principal product is the IzoView breast CT system, designed to produce three-dimensional images of the breast without the compression typically used in conventional mammography. The company’s technology is intended to support breast-cancer screening and diagnostic imaging by providing detailed volumetric images that may help clinicians evaluate breast tissue and abnormalities.